menu
    • menu

    Company profile for South Rampart Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    South Rampart Pharma is a clinical-stage life science company that aims to advance the safe treatment of pain by developing new small-molecule solutions that can overcome many risks associated with current pain medicines. The Company’s pipeline of novel compounds have effectively reduced both pain and fever in preclinical studies without the liver and kidney toxicity of current non-opioid analgesics. The Company’s lead pro...
    South Rampart Pharma is a clinical-stage life science company that aims to advance the safe treatment of pain by developing new small-molecule solutions that can overcome many risks associated with current pain medicines. The Company’s pipeline of novel compounds have effectively reduced both pain and fever in preclinical studies without the liver and kidney toxicity of current non-opioid analgesics. The Company’s lead program SRP-3D (Diethylamide [DA]), is currently in a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics with data expected in the second half of 2022.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    South Rampart PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    478 Broadway Street New Orleans, LA 70118
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://southrampartpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    South Rampart Study Shows SRP-001 Offers Non-Toxic Pain Relief
    South Rampart Study Shows SRP-001 Offers Non-Toxic Pain Relief

    28 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/south-rampart-pharma-announces-new-study-in-neurobiology-of-pain-demonstrating-how-srp-001-delivers-central-non-toxic-pain-relief-302514700.html

    PR NEWSWIRE
    28 Jul 2025
    Share Share
    South Rampart Pharma appoints Ochsner Health CEO Pete November
    South Rampart Pharma appoints Ochsner Health CEO Pete November

    10 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/south-rampart-pharma-strengthens-board-with-appointment-of-ochsner-health-ceo-pete-november-302425121.html

    PR NEWSWIRE
    10 Apr 2025
    Share Share
    South Rampart Publishes SRP-001 Pain Mechanism, Phase 1 Data
    South Rampart Publishes SRP-001 Pain Mechanism, Phase 1 Data

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883210/0/en/South-Rampart-Pharma-Publishes-SRP-001-s-Unique-Pain-Relief-Mechanism-and-Phase-1-Trial-Results-in-Scientific-Reports.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    South Rampart Pharma to Present at Biotech Showcase 2024
    South Rampart Pharma to Present at Biotech Showcase 2024

    03 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/south-rampart-pharma-to-present-at-biotech-showcase-2024-302024127.html

    PR NEWSWIRE
    03 Jan 2024
    Share Share
    South Rampart Completes Phase 1 Study to Include Neuropathic Trials
    South Rampart Completes Phase 1 Study to Include Neuropathic Trials

    02 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/south-rampart-pharma-successfully-completes-phase-1-study-and-expands-phase-2-plans-to-include-neuropathic-and-acute-pain-trials-302024129.html

    PR NEWSWIRE
    02 Jan 2024
    Share Share
    South Rampart Expands Patent Portfolio with EU Approval for SRP-001
    South Rampart Expands Patent Portfolio with EU Approval for SRP-001

    01 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/south-rampart-pharma-expands-global-patent-portfolio-with-eu-approval-for-fda-fast-tracked-srp-001-for-pain-301973561.html

    PR NEWSWIRE
    01 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search